[Use of cavinton in neuropaediatrics].
Studenikin
V M
VM
D000293:Adolescent; D000367:Age Factors; D000368:Aged; D002547:Cerebral Palsy / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009422:Nervous System Diseases / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012737:Sex Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014748:Vinca Alkaloids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D018696:Neuroprotective Agents; D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine